Data / Form D filings / NEXTWAVE PHARMACEUTICALS Inc
NEXTWAVE PHARMACEUTICALS Inc: Form D filing
NEXTWAVE PHARMACEUTICALS Inc, a pharmaceuticals company in Cupertino, CA, filed a Form D with the SEC in 2011. The latest, on January 25, 2011, reports $27.2 million sold of a $45.5 million offering to 11 investors.
Find out what NEXTWAVE PHARMACEUTICALS Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20450 STEVENS CREEK BOULEVARD, SUITE 150, Cupertino, CA, 95014
- Phone
- (408) 342-1300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1389718
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 25, 2011 | New notice | $45,479,417 | $27,229,417 | $18,250,000 | 11 | Jan 10, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Kung | Director | |
| Steve Elms | Director | |
| Gaurav Aggarwal | Director | |
| Dayton Misfeldt | Director | |
| Jay Shepard | Executive Officer, Director | |
| Sally Berry | Executive Officer | |
| Anand Mehra | Director | |
| Robert Casale | Director | |
| Hingge Hsu | Director | |
| Craig Chambliss | Executive Officer | |
| Michael Burdick | Executive Officer | |
| Linda Ara | Executive Officer | |
| Patrick Zenner | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 24, 2011 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NEXTWAVE PHARMACEUTICALS Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.